John Kilichowski

Stock Analyst at Wells Fargo

(3.11)
# 2,584
Out of 5,051 analysts
187
Total ratings
46.5%
Success rate
3.8%
Average return

Stocks Rated by John Kilichowski

CareTrust REIT
Sep 1, 2026
Rated: Buy
Price Target: $53 → $44
Current: $36.03
Upside: +22.12%
Healthpeak Properties
Sep 1, 2026
Reiterated: Hold
Price Target: $22
Current: $18.80
Upside: +17.02%
EPR Properties
Sep 1, 2026
Reiterated: Hold
Price Target: $61
Current: $54.74
Upside: +11.44%
Four Corners Property Trust
Sep 1, 2026
Reiterated: Hold
Price Target: $26
Current: $21.28
Upside: +22.18%
FrontView REIT
Sep 1, 2026
Reiterated: Buy
Price Target: $23
Current: $16.60
Upside: +38.55%
Gaming and Leisure Properties
Sep 1, 2026
Rated: Hold
Price Target: $45 → $43
Current: $38.28
Upside: +12.33%
Janus Living
Sep 1, 2026
Rated: Buy
Price Target: $33 → $35
Current: $28.15
Upside: +24.33%
Medical Properties Trust
Sep 1, 2026
Rated: Sell
Price Target: $5 → $3.8
Current: $3.14
Upside: +21.02%
National Health Investors
Sep 1, 2026
Rated: Hold
Price Target: $79 → $78
Current: $64.85
Upside: +20.28%
National Healthcare Properties
Sep 1, 2026
Rated: Buy
Price Target: $17 → $19
Current: $15.55
Upside: +22.23%
Rated: Hold
Price Target: $49 → $47
Current: $40.24
Upside: +16.80%
Rated: Hold
Price Target: $65 → $64
Current: $54.18
Upside: +18.12%
Rated: Hold
Price Target: $56 → $48
Current: $44.41
Upside: +8.08%
Rated: Hold
Price Target: $27 → $26
Current: $22.88
Upside: +13.64%
Rated: Buy
Price Target: $114 → $104
Current: $82.04
Upside: +26.77%
Rated: Buy
Price Target: $237 → $266
Current: $225.47
Upside: +17.98%
Reiterated: Buy
Price Target: $23
Current: $17.45
Upside: +31.81%
Reiterated: Buy
Price Target: $83 → $92
Current: $65.95
Upside: +39.50%
Rated: Hold
Price Target: $19 → $23
Current: $17.15
Upside: +34.11%
Rated: Hold
Price Target: $39 → $47
Current: $42.46
Upside: +10.69%
Reiterated: Buy
Price Target: $21 → $22
Current: $18.96
Upside: +16.03%
Reiterated: Buy
Price Target: $72
Current: $63.37
Upside: +13.62%
Reiterated: Buy
Price Target: $35
Current: $25.37
Upside: n/a